Twin Peaks Wealth Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Twin Peaks Wealth Advisors's AMGN Position: Q2 2026 in Review
Twin Peaks Wealth Advisors sold out of Amgen (AMGN) in Q2 2026, closing a stake of 509 shares — an estimated $179K sold.
Twin Peaks Wealth Advisors first reported a position in AMGN in Q2 2025 and held it in 2 quarters. The position peaked at $179K in Q1 2026. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Twin Peaks Wealth Advisors reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
- Twin Peaks Wealth Advisors sold 509 Amgen shares in Q2 2026, an estimated $179K.
- Twin Peaks Wealth Advisors first reported a position in Amgen in Q2 2025 and held it in 2 quarters.
- Twin Peaks Wealth Advisors's Amgen position peaked at $179K in Q1 2026.
- 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.